世界の代謝型グルタミン酸受容体市場2020:製造業者別、地域別、種類・用途別

【英語タイトル】Global Metabotropic Glutamate Receptor Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが出版した調査資料(GIR20MY10069)・商品コード:GIR20MY10069
・発行会社(調査会社):GlobalInfoResearch
・発行日:2020年5月(※2024年版があります。お問い合わせください)
・ページ数:106
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:医療・製薬
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,480 ⇒換算¥515,040見積依頼/購入/質問フォーム
Multi User(10名様閲覧用)USD5,220 ⇒換算¥772,560見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD6,960 ⇒換算¥1,030,080見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、代謝型グルタミン酸受容体の世界市場を広く調査・分析し、今後の市場展望をまとめております。代謝型グルタミン酸受容体の種類別市場規模(多糖ワクチン、コンジュゲートワクチン、混合ワクチン、男性Bワクチン)、用途別市場規模(髄膜炎、敗血症、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):Serum Institute (India)、Nuron Biotech (USA)、Sanofi SA (France)、Pfizer (USA)、JN-International Medical (USA)
・地域別グローバル市場分析 2015年-2020年
・代謝型グルタミン酸受容体の北米市場(アメリカ、カナダ、メキシコ)
・代謝型グルタミン酸受容体のヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・代謝型グルタミン酸受容体のアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・代謝型グルタミン酸受容体の南米市場(ブラジル、アルゼンチン)
・代謝型グルタミン酸受容体の中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:多糖ワクチン、コンジュゲートワクチン、混合ワクチン、男性Bワクチン
・用途別分析:髄膜炎、敗血症、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論
【レポートの概要】

Market Overview
The global Metabotropic Glutamate Receptor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 11.5% in the forecast period of 2020 to 2025 and will expected to reach USD 2 million by 2025, from USD 1 million in 2019.

The Metabotropic Glutamate Receptor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Metabotropic Glutamate Receptor market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Metabotropic Glutamate Receptor market has been segmented into
Polysaccharide Vaccines
Conjugate Vaccines
Combination Vaccines
Men B Vaccines

By Application, Metabotropic Glutamate Receptor has been segmented into:
Meningitis
Septicemia
Others

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Metabotropic Glutamate Receptor market presented in the report. This section sheds light on the sales growth of different regional and country-level Metabotropic Glutamate Receptor markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Metabotropic Glutamate Receptor market.

The report offers in-depth assessment of the growth and other aspects of the Metabotropic Glutamate Receptor market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Metabotropic Glutamate Receptor Market Share Analysis
Metabotropic Glutamate Receptor competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Metabotropic Glutamate Receptor sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Metabotropic Glutamate Receptor sales, revenue and market share for each player covered in this report.

The major players covered in Metabotropic Glutamate Receptor are:
Serum Institute (India)
Nuron Biotech (USA)
Sanofi SA (France)
Pfizer (USA)
JN-International Medical (USA)

Among other players domestic and global, Metabotropic Glutamate Receptor market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Metabotropic Glutamate Receptor product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Metabotropic Glutamate Receptor, with price, sales, revenue and global market share of Metabotropic Glutamate Receptor in 2018 and 2019.
Chapter 3, the Metabotropic Glutamate Receptor competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Metabotropic Glutamate Receptor breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Metabotropic Glutamate Receptor market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Metabotropic Glutamate Receptor sales channel, distributors, customers, research findings and conclusion, appendix and data source.

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Metabotropic Glutamate Receptor Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Metabotropic Glutamate Receptor Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Polysaccharide Vaccines
1.2.3 Conjugate Vaccines
1.2.4 Combination Vaccines
1.2.5 Men B Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Metabotropic Glutamate Receptor Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Meningitis
1.3.3 Septicemia
1.3.4 Others
1.4 Overview of Global Metabotropic Glutamate Receptor Market
1.4.1 Global Metabotropic Glutamate Receptor Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Serum Institute (India)
2.1.1 Serum Institute (India) Details
2.1.2 Serum Institute (India) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Serum Institute (India) SWOT Analysis
2.1.4 Serum Institute (India) Product and Services
2.1.5 Serum Institute (India) Metabotropic Glutamate Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Nuron Biotech (USA)
2.2.1 Nuron Biotech (USA) Details
2.2.2 Nuron Biotech (USA) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Nuron Biotech (USA) SWOT Analysis
2.2.4 Nuron Biotech (USA) Product and Services
2.2.5 Nuron Biotech (USA) Metabotropic Glutamate Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Sanofi SA (France)
2.3.1 Sanofi SA (France) Details
2.3.2 Sanofi SA (France) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Sanofi SA (France) SWOT Analysis
2.3.4 Sanofi SA (France) Product and Services
2.3.5 Sanofi SA (France) Metabotropic Glutamate Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer (USA)
2.4.1 Pfizer (USA) Details
2.4.2 Pfizer (USA) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer (USA) SWOT Analysis
2.4.4 Pfizer (USA) Product and Services
2.4.5 Pfizer (USA) Metabotropic Glutamate Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 JN-International Medical (USA)
2.5.1 JN-International Medical (USA) Details
2.5.2 JN-International Medical (USA) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 JN-International Medical (USA) SWOT Analysis
2.5.4 JN-International Medical (USA) Product and Services
2.5.5 JN-International Medical (USA) Metabotropic Glutamate Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Metabotropic Glutamate Receptor Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Metabotropic Glutamate Receptor Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Metabotropic Glutamate Receptor Manufacturer Market Share in 2019
3.3.2 Top 6 Metabotropic Glutamate Receptor Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Metabotropic Glutamate Receptor Sales, Revenue and Market Share by Regions
4.1.1 Global Metabotropic Glutamate Receptor Sales and Market Share by Regions (2015-2020)
4.1.2 Global Metabotropic Glutamate Receptor Revenue and Market Share by Regions (2015-2020)
4.2 North America Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020)
4.3 Europe Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020)
4.5 South America Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Metabotropic Glutamate Receptor Sales, Revenue and Market Share by Country
5.1.1 North America Metabotropic Glutamate Receptor Sales and Market Share by Country (2015-2020)
5.1.2 North America Metabotropic Glutamate Receptor Revenue and Market Share by Country (2015-2020)
5.2 United States Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020)
5.3 Canada Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020)
5.4 Mexico Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Metabotropic Glutamate Receptor Sales, Revenue and Market Share by Country
6.1.1 Europe Metabotropic Glutamate Receptor Sales and Market Share by Country (2015-2020)
6.1.2 Europe Metabotropic Glutamate Receptor Revenue and Market Share by Country (2015-2020)
6.2 Germany Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020)
6.3 UK Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020)
6.4 France Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020)
6.5 Russia Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020)
6.6 Italy Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Metabotropic Glutamate Receptor Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Metabotropic Glutamate Receptor Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Metabotropic Glutamate Receptor Revenue and Market Share by Regions (2015-2020)
7.2 China Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020)
7.3 Japan Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020)
7.4 Korea Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020)
7.5 India Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020)
7.7 Australia Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Metabotropic Glutamate Receptor Sales, Revenue and Market Share by Country
8.1.1 South America Metabotropic Glutamate Receptor Sales and Market Share by Country (2015-2020)
8.1.2 South America Metabotropic Glutamate Receptor Revenue and Market Share by Country (2015-2020)
8.2 Brazil Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020)
8.3 Argentina Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Metabotropic Glutamate Receptor Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Metabotropic Glutamate Receptor Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Metabotropic Glutamate Receptor Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020)
9.3 Turkey Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020)
9.4 Egypt Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020)
9.5 South Africa Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Metabotropic Glutamate Receptor Sales and Market Share by Type (2015-2020)
10.2 Global Metabotropic Glutamate Receptor Revenue and Market Share by Type (2015-2020)
10.3 Global Metabotropic Glutamate Receptor Price by Type (2015-2020)
11 Global Metabotropic Glutamate Receptor Market Segment by Application
11.1 Global Metabotropic Glutamate Receptor Sales Market Share by Application (2015-2020)
11.2 Global Metabotropic Glutamate Receptor Revenue Market Share by Application (2015-2020)
11.3 Global Metabotropic Glutamate Receptor Price by Application (2015-2020)
12 Market Forecast
12.1 Global Metabotropic Glutamate Receptor Sales, Revenue and Growth Rate (2021-2025)
12.2 Metabotropic Glutamate Receptor Market Forecast by Regions (2021-2025)
12.2.1 North America Metabotropic Glutamate Receptor Market Forecast (2021-2025)
12.2.2 Europe Metabotropic Glutamate Receptor Market Forecast (2021-2025)
12.2.3 Asia-Pacific Metabotropic Glutamate Receptor Market Forecast (2021-2025)
12.2.4 South America Metabotropic Glutamate Receptor Market Forecast (2021-2025)
12.2.5 Middle East & Africa Metabotropic Glutamate Receptor Market Forecast (2021-2025)
12.3 Metabotropic Glutamate Receptor Market Forecast by Type (2021-2025)
12.3.1 Global Metabotropic Glutamate Receptor Sales Forecast by Type (2021-2025)
12.3.2 Global Metabotropic Glutamate Receptor Market Share Forecast by Type (2021-2025)
12.4 Metabotropic Glutamate Receptor Market Forecast by Application (2021-2025)
12.4.1 Global Metabotropic Glutamate Receptor Sales Forecast by Application (2021-2025)
12.4.2 Global Metabotropic Glutamate Receptor Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Metabotropic Glutamate Receptor Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Metabotropic Glutamate Receptor by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Metabotropic Glutamate Receptor Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Serum Institute (India) Basic Information, Manufacturing Base and Competitors
Table 8. Serum Institute (India) Metabotropic Glutamate Receptor Major Business
Table 9. Serum Institute (India) Metabotropic Glutamate Receptor Total Revenue (USD Million) (2017-2018)
Table 10. Serum Institute (India) SWOT Analysis
Table 11. Serum Institute (India) Metabotropic Glutamate Receptor Product and Services
Table 12. Serum Institute (India) Metabotropic Glutamate Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Nuron Biotech (USA) Basic Information, Manufacturing Base and Competitors
Table 14. Nuron Biotech (USA) Metabotropic Glutamate Receptor Major Business
Table 15. Nuron Biotech (USA) Metabotropic Glutamate Receptor Total Revenue (USD Million) (2017-2018)
Table 16. Nuron Biotech (USA) SWOT Analysis
Table 17. Nuron Biotech (USA) Metabotropic Glutamate Receptor Product and Services
Table 18. Nuron Biotech (USA) Metabotropic Glutamate Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Sanofi SA (France) Basic Information, Manufacturing Base and Competitors
Table 20. Sanofi SA (France) Metabotropic Glutamate Receptor Major Business
Table 21. Sanofi SA (France) Metabotropic Glutamate Receptor Total Revenue (USD Million) (2017-2018)
Table 22. Sanofi SA (France) SWOT Analysis
Table 23. Sanofi SA (France) Metabotropic Glutamate Receptor Product and Services
Table 24. Sanofi SA (France) Metabotropic Glutamate Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Pfizer (USA) Basic Information, Manufacturing Base and Competitors
Table 26. Pfizer (USA) Metabotropic Glutamate Receptor Major Business
Table 27. Pfizer (USA) Metabotropic Glutamate Receptor Total Revenue (USD Million) (2017-2018)
Table 28. Pfizer (USA) SWOT Analysis
Table 29. Pfizer (USA) Metabotropic Glutamate Receptor Product and Services
Table 30. Pfizer (USA) Metabotropic Glutamate Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. JN-International Medical (USA) Basic Information, Manufacturing Base and Competitors
Table 32. JN-International Medical (USA) Metabotropic Glutamate Receptor Major Business
Table 33. JN-International Medical (USA) Metabotropic Glutamate Receptor Total Revenue (USD Million) (2017-2018)
Table 34. JN-International Medical (USA) SWOT Analysis
Table 35. JN-International Medical (USA) Metabotropic Glutamate Receptor Product and Services
Table 36. JN-International Medical (USA) Metabotropic Glutamate Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global Metabotropic Glutamate Receptor Sales by Manufacturer (2018-2019) (K Units)
Table 38. Global Metabotropic Glutamate Receptor Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global Metabotropic Glutamate Receptor Sales by Regions (2015-2020) (K Units)
Table 40. Global Metabotropic Glutamate Receptor Sales Market Share by Regions (2015-2020)
Table 41. Global Metabotropic Glutamate Receptor Revenue by Regions (2015-2020) (USD Million)
Table 42. North America Metabotropic Glutamate Receptor Sales by Countries (2015-2020) (K Units)
Table 43. North America Metabotropic Glutamate Receptor Sales Market Share by Countries (2015-2020)
Table 44. North America Metabotropic Glutamate Receptor Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Metabotropic Glutamate Receptor Revenue Market Share by Countries (2015-2020)
Table 46. Europe Metabotropic Glutamate Receptor Sales by Countries (2015-2020) (K Units)
Table 47. Europe Metabotropic Glutamate Receptor Sales Market Share by Countries (2015-2020)
Table 48. Europe Metabotropic Glutamate Receptor Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific Metabotropic Glutamate Receptor Sales by Regions (2015-2020) (K Units)
Table 50. Asia-Pacific Metabotropic Glutamate Receptor Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific Metabotropic Glutamate Receptor Revenue by Regions (2015-2020) (USD Million)
Table 52. South America Metabotropic Glutamate Receptor Sales by Countries (2015-2020) (K Units)
Table 53. South America Metabotropic Glutamate Receptor Sales Market Share by Countries (2015-2020)
Table 54. South America Metabotropic Glutamate Receptor Revenue by Countries (2015-2020) (USD Million)
Table 55. South America Metabotropic Glutamate Receptor Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Metabotropic Glutamate Receptor Sales by Countries (2015-2020) (K Units)
Table 57. Middle East & Africa Metabotropic Glutamate Receptor Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Metabotropic Glutamate Receptor Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa Metabotropic Glutamate Receptor Revenue Market Share by Countries (2015-2020)
Table 60. Global Metabotropic Glutamate Receptor Sales by Type (2015-2020) (K Units)
Table 61. Global Metabotropic Glutamate Receptor Sales Share by Type (2015-2020)
Table 62. Global Metabotropic Glutamate Receptor Revenue by Type (2015-2020) (USD Million)
Table 63. Global Metabotropic Glutamate Receptor Revenue Share by Type (2015-2020)
Table 64. Global Metabotropic Glutamate Receptor Sales by Application (2015-2020) (K Units)
Table 65. Global Metabotropic Glutamate Receptor Sales Share by Application (2015-2020)
Table 66. Global Metabotropic Glutamate Receptor Sales Forecast by Regions (2021-2025) (K Units)
Table 67. Global Metabotropic Glutamate Receptor Market Share Forecast by Regions (2021-2025)
Table 68. Global Metabotropic Glutamate Receptor Sales Forecast by Type (2021-2025) (K Units)
Table 69. Global Metabotropic Glutamate Receptor Market Share Forecast by Type (2021-2025)
Table 70. Global Metabotropic Glutamate Receptor Sales Forecast by Application (2021-2025)
Table 71. Global Metabotropic Glutamate Receptor Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Metabotropic Glutamate Receptor Picture
Figure 2. Global Sales Market Share of Metabotropic Glutamate Receptor by Type in 2019
Figure 3. Polysaccharide Vaccines Picture
Figure 4. Conjugate Vaccines Picture
Figure 5. Combination Vaccines Picture
Figure 6. Men B Vaccines Picture
Figure 7. Metabotropic Glutamate Receptor Sales Market Share by Application in 2018
Figure 8. Meningitis Picture
Figure 9. Septicemia Picture
Figure 10. Others Picture
Figure 11. Global Metabotropic Glutamate Receptor Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Metabotropic Glutamate Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Metabotropic Glutamate Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Metabotropic Glutamate Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Metabotropic Glutamate Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Metabotropic Glutamate Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Metabotropic Glutamate Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Metabotropic Glutamate Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Metabotropic Glutamate Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Metabotropic Glutamate Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Metabotropic Glutamate Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Metabotropic Glutamate Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Metabotropic Glutamate Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Metabotropic Glutamate Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Metabotropic Glutamate Receptor Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Metabotropic Glutamate Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Metabotropic Glutamate Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Metabotropic Glutamate Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Metabotropic Glutamate Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Metabotropic Glutamate Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Metabotropic Glutamate Receptor Sales Market Share by Manufacturer in 2019
Figure 32. Global Metabotropic Glutamate Receptor Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Metabotropic Glutamate Receptor Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Metabotropic Glutamate Receptor Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Metabotropic Glutamate Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Metabotropic Glutamate Receptor Revenue Market Share by Regions (2015-2020)
Figure 39. Global Metabotropic Glutamate Receptor Revenue Market Share by Regions in 2018
Figure 40. North America Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020)
Figure 41. Europe Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020)
Figure 43. South America Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020)
Figure 45. North America Metabotropic Glutamate Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Metabotropic Glutamate Receptor Sales Market Share by Countries (2015-2020)
Figure 47. North America Metabotropic Glutamate Receptor Sales Market Share by Countries in 2018
Figure 48. North America Metabotropic Glutamate Receptor Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Metabotropic Glutamate Receptor Revenue Market Share by Countries in 2018
Figure 50. United States Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Metabotropic Glutamate Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Metabotropic Glutamate Receptor Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Metabotropic Glutamate Receptor Revenue Market Share by Countries in 2019
Figure 56. Germany Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Metabotropic Glutamate Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Metabotropic Glutamate Receptor Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Metabotropic Glutamate Receptor Revenue Market Share by Regions 2019
Figure 64. China Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Metabotropic Glutamate Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Metabotropic Glutamate Receptor Sales Market Share by Countries in 2019
Figure 71. South America Metabotropic Glutamate Receptor Revenue Market Share by Countries in 2019
Figure 72. Brazil Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Metabotropic Glutamate Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Metabotropic Glutamate Receptor Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Metabotropic Glutamate Receptor Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Metabotropic Glutamate Receptor Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Metabotropic Glutamate Receptor Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Metabotropic Glutamate Receptor Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Metabotropic Glutamate Receptor Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Metabotropic Glutamate Receptor Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Metabotropic Glutamate Receptor Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Metabotropic Glutamate Receptor Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Metabotropic Glutamate Receptor Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Metabotropic Glutamate Receptor Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel


【掲載企業】

Serum Institute (India)、Nuron Biotech (USA)、Sanofi SA (France)、Pfizer (USA)、JN-International Medical (USA)

★調査レポート[世界の代謝型グルタミン酸受容体市場2020:製造業者別、地域別、種類・用途別] (コード:GIR20MY10069)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の代謝型グルタミン酸受容体市場2020:製造業者別、地域別、種類・用途別]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆